COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 810: Articles 8091-8100  | Next

A 21L/BA.2-21K/BA.1 MixOmicron SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis
Colson, P., Delerce, J., Marion-Paris, E., Lagier, J.-C., Bedotto, M., LEVASSEUR, A., Fournier, P.-E., LA SCOLA, B., Raoult, D.
10.1101/2022.03.28.22273010 — Posted: 2022-03-31
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV: a nationwide prospective cohort study in the Netherlands
Hensley, K. S., Jongkees, M. J., Geers, D., GeurtsvanKessel, C. H., Mueller, Y. M., Dalm, V. A. S. H., Papageorgiou, G., Steggink, H., Gorska, A., Bogers, S., den Hollander, J. G., Bierman, W. F. W., Gelinck, L. B. S., Schippers, E. F., Ammerlaan, H. S. M., van der Valk, M., van Vonderen, M. G. A., Delsing, C. E., Gisolf, E. H., Bruns, A. H. W., Lauw, F. N., Berrevoets, M. A. H., Sigaloff, K. C. E., Soetekouw, R., Branger, J., de Mast, Q., Lammers, A. J. J., Lowe, S. H., de Vries, R. D., Katsikis, P. D., Rijnders, B. J. A., Brinkman, K., Roukens, A. H. E., Rokx, C.
10.1101/2022.03.31.22273221 — Posted: 2022-03-31
A Wide-bandwidth Nanocomposite-Sensor Integrated Smart Mask for Tracking Multi-phase Respiratory Activities for COVID-19 Endemic
Suo, J., Liu, Y., Wu, C., Chen, M., Huang, Q., Liu, Y., Yao, K., Chen, Y., Pan, Q., Chang, X., Chan, H.-y., Zhang, G., Yang, Z., Daoud, W., Li, X., Vellaisamy, R., Yu, X., Wang, J., Li, W. J.
10.1101/2022.03.28.22273021 — Posted: 2022-03-31
SARS-CoV-2 Omicron is specifically restricted in its replication in human lung tissue, compared to other variants of concern
Alfi, O., Hamdan, M., Wald, O., Yakirevitch, A., Wandel, O., Oiknine-Djian, E., Gvili, B., Knoller, H., Rozendorn, N., Golan Berman, H., Adar, S., Vorontsov, O., Mandelboim, M., Zakay-Rones, Z., Oberbaum, M., Panet, A., Wolf, D.
10.1101/2022.03.31.486531 — Posted: 2022-03-31
No magic bullet: limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
Van Egeren, D., Stoddard, M., Malakar, A., Ghosh, D., Acharya, A., Mainuddin, S., Majumdar, B., Luo, D., Nolan, R., Joseph-McCarthy, D., White, L. F., Hochberg, N. S., Basu, S., Chakravarty, A.
10.1101/2022.03.25.22272956 — Posted: 2022-03-31
Prediction of infectivity of SARS-CoV2: Mathematical Model with Docking Simulation analysis between Spike Protein and ACE2
Takaoka, Y., Sugano, A., Morinaga, Y., Ohta, M., Miura, K., Kataguchi, H., Kumaoka, M., Kimura, S., Maniwa, Y.
10.1101/2022.03.30.486373 — Posted: 2022-03-31
Identification of C270 as a novel site for allosteric modulators of SARS-CoV-2 papain-like protease
Hu, H., Wang, Q., Su, H., Shao, Q., Zhao, W., Chen, G., Li, M., Xu, Y.
10.1101/2022.03.30.486313 — Posted: 2022-03-31
Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2Omicron variant BA.1 infection of human airway epithelial explant cultures
Volle, R., Murer, L., Petkidis, A., Andriasyan, V., Savi, A., Bircher, C., Meili, N., Fisher, L., Sequeira, D. P., Mark, D. K., Gonzalez, A. G., Greber, U. F.
10.1101/2022.03.30.486461 — Posted: 2022-03-31
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
Demarest, J. F., Kienle, M., Boytz, R., Ayres, M., Kim, E., Chung, D., Gandhi, V., Davey, R. A., Sykes, D. B., Shohdy, N., Pottage, J. C., Kumar, V. S.
10.1101/2022.03.30.486499 — Posted: 2022-03-31
Cross neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
Zou, J., Kurhade, C., Xia, H., Liu, M., Xie, X., Ren, P., Shi, P.-Y.
10.1101/2022.03.30.486409 — Posted: 2022-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).